Gajanand Biotech Products Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 63.99%
- Ebitda 72.83%
- Net Worth -29.43%
- Total Assets -3.99%
About Gajanand Biotech Products
Gajanand Biotech Products Private Limited (GBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 December 2017 (Seven years and two months 17 days old ). Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Arvind Sharma and Sunil Sharma serve as directors at the Company.
Company Details
- Location
Faridabad, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U36999HR2017PTC071770
- Company No.
071770
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Gajanand Biotech Products?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Sharma  | Director | 08-Dec-2017 | Current |
| Sunil Sharma | Director | 08-Dec-2017 | Current |
Financial Performance of Gajanand Biotech Products.
Gajanand Biotech Products Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 63.99% increase in profit. The company's net worth observed a substantial decline by a decrease of 29.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gajanand Biotech Products?
Unlock access to Gajanand Biotech Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gajanand Biotech Products?
Unlock and access historical data on people associated with Gajanand Biotech Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gajanand Biotech Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gajanand Biotech Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.